Dr Rajesh Jain's Insider Trades & SAST Disclosures
Dr Rajesh Jain's most recent trade in Panacea Biotec Ltd. was a Acquisition of 5,000,000 Equity Shares done . Disclosure was reported to the exchange on April 4, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Dr Rajesh Jain's has made SAST transactions in Panacea Biotec Ltd. recently where a Pledge of 4,647,799 shares done . Disclosure was reported to the exchange on Sept. 9, 2020.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Dr Rajesh Jain.To see full superstar portfolios of large investors like Jhunjhunwala, Damani and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Panacea Biotec | Dr Rajesh Jain | Promoter | Pledge | 24 Dec 2024 | 4,647,799 | 10,861,299 | - | - | 08 Sep 2020 08 Sep 2020 |
SAST (Reg31) | - | Creation | |
| Panacea Biotec | Dr Rajesh Jain | Promoter | Pledge | 24 Dec 2024 | 2,858,213 | 13,719,512 | - | - | 14 Sep 2020 14 Sep 2020 |
SAST (Reg31) | - | Creation | |
| Ravinder Heights | Dr Rajesh Jain | Promoter | Pledge | 24 Dec 2024 | 13,719,512 | 13,719,512 | - | - | 06 Oct 2020 06 Oct 2020 |
SAST (Reg31) | - | Creation | |
| Ravinder Heights | Dr Rajesh Jain | Promoter | Pledge | 24 Dec 2024 | 13,719,512 | 0 | - | - | 07 Jan 2021 07 Jan 2021 |
SAST (Reg31) | - | Release | |
| Panacea Biotec | Dr Rajesh Jain | Promoter | Pledge | 24 Dec 2024 | 11,229,584 | 24,949,096 | - | - | 15 Jan 2021 15 Jan 2021 |
SAST (Reg31) | - | Creation | |
| Panacea Biotec | Dr. Rajesh Jain | Promoter | Pledge | 24 Dec 2024 | 65,700 | 6,504,300 | - | - | 22 Feb 2021 22 Feb 2021 |
SAST (Reg31) | - | Release | |
| Panacea Biotec | Dr. Rajesh Jain | Promoter | Pledge | 24 Dec 2024 | 6,504,300 | 0 | - | - | 15 Mar 2022 |
SAST (Reg31) | - | Release | |
| Panacea Biotec | Dr. Rajesh Jain | Promoter | Pledge | 24 Dec 2024 | 24,949,096 | 0 | - | - | 15 Mar 2022 |
SAST (Reg31) | - | Release | |
| Panacea Biotec | Dr. Rajesh Jain | Promoter | Acquisition | 04 Apr 2023 | 5,000,000 | 30,217,312 (13.57%) | 8.16% | 0 | 0 | 29 Mar 2023 29 Mar 2023 |
Insider Trading | Equity Shares | Inheritance |
| Panacea Biotec | Dr. Rajesh Jain | Promoter | Acquisition | 04 Apr 2023 | 6,504,300 | 13,008,600 (58.43%) | 10.62% | 0 | 0 | 29 Mar 2023 29 Mar 2023 |
Insider Trading | Preference Shares | Inheritance |
| Panacea Biotec | Dr Rajesh Jain | Promoter | Acquisition | 01 Apr 2023 | 5,000,000 | 30,217,312 (13.57%) | 2.25% | - | 29 Mar 2023 29 Mar 2023 |
SAST (29(2)) | - | Off Market | |
| Ravinder Heights | Dr. Rajesh Jain | Promoter Group | Disposal | 06 Jan 2022 | 751,938 | 0 (0%) | 1.23% | 0 | 0 | 04 Jan 2022 04 Jan 2022 |
Insider Trading | Equity Shares | Gift |
| Ravinder Heights | Dr Rajesh Jain | Promoter | Acquisition | 21 Apr 2022 | 140,000 | 749,999 (1.22%) | 0.22% | - | 19 Apr 2022 19 Apr 2022 |
SAST (29(2)) | - | Market | |
| Ravinder Heights | Dr. Rajesh Jain | Promoter | Acquisition | 12 Apr 2022 | 609,999 | 609,999 (1%) | 1% | - | 07 Apr 2022 07 Apr 2022 |
SAST (29(2)) | - | Inter-se Transfer | |
| Ravinder Heights | Dr Rajesh Jain HUF | Other | Acquisition | 11 Apr 2022 | 600,000 | 600,000 (0.98%) | 0.98% | - | 06 Apr 2022 06 Apr 2022 |
SAST (29(2)) | - | Market | |
| Ravinder Heights | Dr. Rajesh Jain | Promoter Group | Acquisition | 30 Dec 2021 | 751,938 | 751,938 (1.23%) | 1.23% | 23.2 | 17,444,962 | 27 Dec 2021 27 Dec 2021 |
Insider Trading | Equity Shares | Off Market |
| Ravinder Heights | Dr Rajesh Jain | Promoter | Acquisition | 28 Dec 2021 | 751,938 | 751,938 (1.23%) | 1.23% | - | 27 Dec 2021 27 Dec 2021 |
SAST (29(2)) | - | Off Market | |
| Panacea Biotec | Dr Rajesh Jain | None | Acquisition | 13 Jan 2021 | 11,497,800 | - | 18.77% | - | 08 Jan 2021 08 Jan 2021 |
SAST (10(6)) | - | None | |
| Panacea Biotec | Dr. Rajesh Jain | Promoter & Director | Acquisition | 13 Jan 2021 | 11,497,800 | 25,217,312 (41.17%) | 18.76% | 0 | 0 | 08 Jan 2021 08 Jan 2021 |
Insider Trading | Equity Shares | Gift |
| Ravinder Heights | Dr Rajesh Jain | Promoter | Disposal | 11 Jan 2021 | 13,719,512 | - | 22.40% | - | 07 Jan 2021 07 Jan 2021 |
SAST (29(2)) | - | Inter-se Transfer / Gift | |
| Panacea Biotec | Dr Rajesh Jain | Promoter | Acquisition | 11 Jan 2021 | 11,497,800 | 25,217,312 (11.32%) | 5.16% | - | 08 Jan 2021 08 Jan 2021 |
SAST (29(2)) | - | Inter-se Transfer / Gift | |
| Panacea Biotec | Dr Rajesh Jain | Promoter | Acquisition | 23 Dec 2020 | 11,497,800 | - | 5.16% | - | 29 Dec 2020 29 Dec 2020 |
SAST (10(1)(a)) | - | None | |
| Panacea Biotec | Dr. Rajesh Jain | None | Acquisition | 16 Sep 2020 | 4,647,799 | - | 6.80% | - | 08 Sep 2020 08 Sep 2020 |
SAST (10(6)) | - | None | |
| Panacea Biotec | Dr Rajesh Jain | Promoter | Disposal | 16 Sep 2020 | 307,000 | - | 0.14% | - | 12 Sep 2020 12 Sep 2020 |
SAST (29(2)) | - | Inter-se Transfer / Gift | |
| Panacea Biotec | Dr. Rajesh Jain | Promoter | Acquisition | 15 Sep 2020 | 2,858,213 | 13,719,512 (6.12%) | 1.27% | - | 10 Sep 2020 12 Sep 2020 |
SAST (29(2)) | - | Inter-se Transfer / Gift | |
| Panacea Biotec | Dr. Rajesh Jain | Promoter | Disposal | 15 Sep 2020 | 2,251,713 | - | 1% | - | 10 Sep 2020 12 Sep 2020 |
SAST (29(2)) | - | Inter-se Transfer / Gift | |
| Panacea Biotec | Dr Rajesh Jain | Promoter | Disposal | 15 Sep 2020 | 299,500 | - | 0.13% | - | 10 Sep 2020 10 Sep 2020 |
SAST (29(2)) | - | Inter-se Transfer / Gift | |
| Panacea Biotec | Dr Rajesh Jain | Promoter | Disposal | 10 Sep 2020 | 897,000 | - | 0.40% | - | 08 Sep 2020 08 Sep 2020 |
SAST (29(2)) | - | Inter-se Transfer / Gift | |
| Panacea Biotec | Dr Rajesh Jain | Promoter | Disposal | 10 Sep 2020 | 3,750,799 | - | 1.67% | - | 08 Sep 2020 08 Sep 2020 |
SAST (29(2)) | - | Inter-se Transfer / Gift | |
| Panacea Biotec | Dr Rajesh Jain | Promoter | Acquisition | 10 Sep 2020 | 4,647,799 | 10,861,299 (4.84%) | 2.07% | - | 08 Sep 2020 08 Sep 2020 |
SAST (29(2)) | - | Inter-se Transfer / Gift | |
| Panacea Biotec | Dr. Rajesh Jain | Promoter | Acquisition | 01 Sep 2020 | 7,506,012 | - | 12.25% | - | 07 Sep 2020 07 Sep 2020 |
SAST (10(1)(a)) | - | None |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.